Barclays Boosts Humana (NYSE:HUM) Price Target to $255.00

Humana (NYSE:HUM) had its price objective lifted by Barclays from $253.00 to $255.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the insurance provider’s stock. Barclays‘s target price would indicate a potential downside of 13.03% from the company’s previous close.

Several other equities research analysts have also recently issued reports on HUM. Royal Bank of Canada dropped their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Piper Sandler lifted their price objective on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Jefferies Financial Group downgraded Humana from a “buy” rating to a “hold” rating and lowered their target price for the company from $519.00 to $253.00 in a report on Monday, October 7th. UBS Group cut their price target on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, October 4th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research note on Thursday, October 3rd. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Humana currently has an average rating of “Hold” and an average target price of $302.80.

Humana Stock Up 2.9 %

HUM stock opened at $293.22 on Wednesday. The stock has a market capitalization of $35.31 billion, a P/E ratio of 25.97, a P/E/G ratio of 2.15 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana has a 1-year low of $213.31 and a 1-year high of $411.80. The business has a fifty day moving average price of $273.81 and a 200-day moving average price of $305.88.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities analysts forecast that Humana will post 16.11 earnings per share for the current fiscal year.

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.32% of the company’s stock.

Institutional Investors Weigh In On Humana

Several institutional investors and hedge funds have recently modified their holdings of HUM. State Street Corp grew its stake in Humana by 1.0% during the third quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock valued at $1,701,582,000 after acquiring an additional 53,272 shares in the last quarter. FMR LLC boosted its holdings in shares of Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the last quarter. Pzena Investment Management LLC grew its position in shares of Humana by 8.1% during the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after purchasing an additional 187,903 shares in the last quarter. Legal & General Group Plc increased its holdings in shares of Humana by 2.1% in the second quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock worth $442,396,000 after purchasing an additional 24,842 shares during the last quarter. Finally, Ontario Teachers Pension Plan Board lifted its position in shares of Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after buying an additional 71,910 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.